Search Results - "Lapin, Morten"
-
1
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Published in Journal of translational medicine (06-11-2018)“…It was recently demonstrated that the size of cell-free DNA (cfDNA) fragments that originates from tumor cells are shorter than cfDNA fragments that originates…”
Get full text
Journal Article -
2
Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
Published in PloS one (14-09-2023)“…Tumor-derived extracellular vesicles (EVs) are reported to contain nucleic acids, including DNA. Several studies have highlighted the potential of EV-derived…”
Get full text
Journal Article -
3
Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing
Published in Scientific reports (06-04-2022)“…Circulating tumor DNA (ctDNA) analysis has emerged as a clinically useful tool for cancer diagnostics and treatment monitoring. However, ctDNA detection is…”
Get full text
Journal Article -
4
Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
Published in BMC cancer (31-05-2017)“…Single-cell mRNA profiling of circulating tumour cells may contribute to a better understanding of the biology of these cells and their role in the metastatic…”
Get full text
Journal Article -
5
High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling
Published in International journal of molecular sciences (29-12-2021)“…Implementation of high-risk human papilloma virus (HPV) screening and the increasing proportion of HPV vaccinated women in the screening program will reduce…”
Get full text
Journal Article -
6
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
Published in Molecular oncology (01-09-2023)“…Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a need for better tools to guide treatment selection and follow-up. The aim of this…”
Get full text
Journal Article -
7
Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study
Published in BMC cancer (03-06-2022)“…Although pancreatic ductal adenocarcinoma (PDAC) rarely metastasizes to the skeleton, disseminated tumor cells have been detected in bone marrow samples from…”
Get full text
Journal Article -
8
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer
Published in PLoS genetics (19-05-2016)“…Costello syndrome (CS) may be caused by activating mutations in codon 12/13 of the HRAS proto-oncogene. HRAS p.Gly12Val mutations have the highest transforming…”
Get full text
Journal Article -
9
Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
Published in Clinical cancer research (03-04-2023)“…Circulating tumor DNA (ctDNA) has emerged as a promising tumor-specific biomarker in pancreatic cancer, but current evidence of the clinical potential of ctDNA…”
Get full text
Journal Article -
10
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
Published in Scientific reports (19-07-2016)“…Most current methods of circulating tumour cell (CTC) enrichment target the epithelial protein EpCAM, which is commonly expressed in adenocarcinoma cells…”
Get full text
Journal Article -
11
Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer
Published in Molecular oncology (01-04-2016)“…We used KRAS mutations to investigate the clinical relevance of circulating tumor DNA (ctDNA) measurements in patients with advanced pancreatic cancer…”
Get full text
Journal Article -
12
Abstract 5593: The fragment size and levels of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Purpose: To investigate the prognostic value of cell-free DNA (cfDNA) fragment size and cfDNA levels in patients with advanced pancreatic cancer. Methods:…”
Get full text
Journal Article -
13
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures
Published in The oncologist (Dayton, Ohio) (06-04-2023)“…Abstract Detection of methylation patterns in circulating tumor DNA (ctDNA) can offer a novel approach for cancer diagnostics given the unique signature for…”
Get full text
Journal Article -
14
Abstract LB-252: Single-cell mRNA profiling reveal transcriptional heterogeneity among pancreatic circulating tumor cells
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Background: Single-cell analysis of the transcriptional heterogeneity of circulating tumor cells have the prospect of better understanding the biology of these…”
Get full text
Journal Article -
15
Abstract 2287: Circulating extracellular vesicles from patients with advanced pancreatic cancer contain low levels of tumor-derived DNA
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Purpose: Extracellular vesicles (EVs) have been shown to contain nucleic acids, including DNA. Several studies have highlighted the potential of EV-derived DNA…”
Get full text
Journal Article -
16
Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer
Published in PloS one (01-01-2023)Get full text
Journal Article -
17
Abstract 734: Monitoring of dynamic changes and clonal evolution in circulating tumor DNA from patients with IDH-mutated cholangiocarcinoma treated with IDH inhibitors
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Background: IDH mutations are prevalent in up to 30% of patients with cholangiocarcinoma and IDH inhibitors are in the late stage of clinical development…”
Get full text
Journal Article -
18
-
19
Real-world experience of the decentralized MSK-ACCESS powered with SOPHiA DDM solution
Published in Journal of Liquid Biopsy (01-11-2024)Get full text
Journal Article -
20
Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System
Published in Cancers (13-04-2021)“…Liquid biopsies have emerged as a potential new diagnostic tool, providing detailed information relevant for characterization and treatment of solid cancers…”
Get full text
Journal Article